Drug Type Synthetic peptide |
Synonyms- |
Target |
Action stimulants, agonists |
Mechanism IL-6 stimulants(Interleukin-6 stimulants), IL-8 agonists(Interleukin-8 agonists) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC98H141N25O23S4 |
InChIKeyAHMZTHYNOXWCBS-CWULFHHCSA-N |
CAS Registry117978-77-5 |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Methicillin-Resistant Staphylococcus Epidermidis (MRSE) Infection | Preclinical | Sweden | 13 Mar 2018 | |
| MRSA - Methicillin resistant Staphylococcus aureus infection | Preclinical | Sweden | 13 Mar 2018 |






